Per ulteriori informazioni selezionare i riferimenti di interesse.
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma
CLINICAL CANCER RESEARCH
High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules
CANCER RESEARCH
Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII
CANCER IMMUNOLOGY IMMUNOTHERAPY
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon
MEDICAL ONCOLOGY
SUPERANTIGEN-TARGETED THERAPY - PHASE-I ESCALATING REPEAT DOSE TRIAL OF THE FUSION PROTEIN PNU-214565 IN PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES
Clinical cancer research
OVERVIEW OF CLINICAL-TRIALS EMPLOYING ANTIBODY-TARGETED SUPERANTIGENS
Advanced drug delivery reviews
SUPERANTIGEN-BASED IMMUNOTHERAPY - A PHASE-I TRIAL OF PNU-214565, A MONOCLONAL-ANTIBODY STAPHYLOCOCCAL-ENTEROTOXIN A RECOMBINANT FUSION PROTEIN, IN ADVANCED PANCREATIC AND COLORECTAL-CANCER
Journal of clinical oncology
REDIRECTED CELLULAR CYTOTOXICITY EMPLOYING BISPECIFIC ANTIBODIES AND OTHER MULTIFUNCTIONAL BINDING-PROTEINS
Cancer immunology and immunotherapy
INDUCTION OF MULTIPLE ANTI-C-ERB-2 SPECIFICITIES ACCOMPANIES A CLASSICAL IDIOTYPIC CASCADE FOLLOWING 2B1 BISPECIFIC MONOCLONAL-ANTIBODY TREATMENT
Cancer immunology and immunotherapy
HUMAN NEUTROPHIL INTERACTIONS OF A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING TUMOR AND HUMAN FC-GAMMA-RIII
Cancer immunology and immunotherapy
BINDING CHARACTERISTICS AND ANTITUMOR PROPERTIES OF 1A10 BISPECIFIC ANTIBODY RECOGNIZING GP40 AND HUMAN TRANSFERRIN RECEPTOR
Cancer research
RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN NONHUMAN-PRIMATES - SELECTIVE EXPANSION OF A CD16(-KILLER-CELLS() MONOCYTE SUBSETWITH PHENOTYPIC SIMILARITY TO PRIMATE NATURAL)
Blood
PHASE-I TRIAL OF 2B1, A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING C-ERBB-2 AND FC-GAMMA-RIII
Cancer research
CD16(- SPONTANEOUS ELEVATION AND PHARMACOLOGICAL INDUCTION BY RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR() MONOCYTES IN PATIENTS WITH CANCER )
Blood
PHASE-I TRIAL OF RECOMBINANT MACROPHAGE-COLONY-STIMULATING FACTOR ANDRECOMBINANT GAMMA-INTERFERON - TOXICITY, MONOCYTOSIS, AND CLINICAL EFFECTS
Cancer research
BINDING AND CYTOTOXICITY CHARACTERISTICS OF THE BISPECIFIC MURINE MONOCLONAL ANTIBODY-2B1
The Journal of immunology